Welcome to our dedicated page for Tactile Systems news (Ticker: TCMD), a resource for investors and traders seeking the latest updates and insights on Tactile Systems stock.
Tactile Systems Technology, Inc. reports news as a medical technology company that develops and markets at-home therapies for chronic disorders. Its updates center on lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease, including products and platforms such as Flexitouch Plus, AffloVest airway clearance devices and LymphaTech's digital 3D measurement and monitoring technology.
Recurring company developments include quarterly financial results, clinical evidence for home-based therapies, FDA device clearances, product portfolio expansion, order-management and reimbursement workflow initiatives, acquisitions, share repurchase activity and board governance changes. The company's news also describes its work with clinicians to expand awareness and access to care for patients using at-home therapy systems.
Tactile Systems Technology (Nasdaq: TCMD) announced it will release its first quarter 2021 financial results after market close on May 3. The management team will host a conference call at 5:00 p.m. ET to discuss these results. Participants can dial in using 877-407-3088 (or 201-389-0927 for international) with access code 13718669. A live webcast will also be available on the investor relations section of Tactile Medical's website. The company specializes in at-home treatment devices for chronic conditions like lymphedema.
Tactile Systems Technology, Inc. (Nasdaq: TCMD) announced Kristie Burns as the new Senior Vice President of Marketing & Clinical Affairs, effective March 22, 2021. Burns, who has over 25 years of experience in the healthcare sector, succeeds Darren Wennen, now Senior VP of Commercial Operations. Previously, Burns held executive roles at Cala Health and ResMed, focusing on chronic condition treatments. Tactile Medical aims to enhance its market penetration under her leadership, which could improve access to critical therapies for patients with chronic diseases.
Tactile Systems Technology (TCMD) reported a 4% increase in fourth-quarter revenue for 2020, reaching $59.2 million, compared to $57.1 million in Q4 2019. The net income surged to $12.1 million, a significant rise from $4.3 million a year earlier. However, overall revenue for the year decreased by 1% to $187.1 million. Despite facing challenges from the COVID-19 pandemic, the company aims for a 15% to 20% revenue growth in 2021, forecasting total revenue between $215.3 million and $224.5 million. Cash and equivalents stood at $47.9 million at year-end.
Tactile Systems Technology, Inc. (Nasdaq: TCMD) announced participation in two upcoming investor conferences.
Management will engage in a virtual fireside chat on February 17 at 9:30 a.m. ET during the BTIG Virtual MedTech Conference. Additionally, they will present at the Oppenheimer 31st Annual Healthcare Conference on March 16 at 10:40 a.m. ET.
Audio webcasts will be accessible on the company’s investor relations website and available for replay after the events.
Tactile Medical specializes in home therapy devices for chronic diseases, focusing on improving patient care and reducing healthcare costs.
Tactile Systems Technology (TCMD) will release its fourth quarter and fiscal year 2020 financial results after market close on February 23, 2021. Management will host a conference call at 5:00 p.m. ET on the same day to discuss the financial outcomes and answer questions from participants. Investors can join the call via phone or through a live webcast on their investor relations website. The archived call will be available for two weeks, ensuring that shareholders can review the details of the financial performance and strategic insights shared during the event.
Tactile Systems Technology (Nasdaq: TCMD) has appointed Sheri Dodd and Deepti Jain to its Board of Directors, effective January 1, 2021. Dodd, Vice President at Medtronic, brings extensive healthcare management experience, while Jain previously served as President of IngenioRx, managing a significant pharmacy business. Their appointments follow the resignation of Dr. Cheryl Pegus, who took a new position at Walmart. The company aims to enhance its focus on disease management and patient services through this leadership transition.
Tactile Systems Technology, Inc. (Nasdaq: TCMD) announced its participation in a fireside chat at the ICR Conference 2021, scheduled for January 14th at 8:30 a.m. Eastern Time. The event will be held virtually from January 11th-14th. A live audio webcast will be available on the Company's investor relations website, with an archive accessible for replay after the event. Tactile Medical specializes in at-home therapy devices for chronic conditions like lymphedema, aiming to improve patients' quality of life while managing healthcare costs.
Tactile Systems Technology (TCMD) has announced its participation in several upcoming investor conferences. Management will engage in virtual 1x1 meetings at the Oppenheimer Fall MedTech Summit on November 12 and at the Canaccord Genuity Virtual MedTech & Diagnostics Forum on November 19. Additionally, a fireside chat will take place during the 32nd Annual Piper Sandler Healthcare Conference from December 1 to 3, accessible via the company’s investor relations website. This participation underscores TCMD's commitment to advancing at-home therapies for chronic conditions.
Tactile Systems Technology (TCMD) reported a 1% decrease in Q3 2020 revenue to $49.1 million compared to $49.6 million in Q3 2019, with COVID-19 impacting results. Operating income fell 44% to $1.8 million, while adjusted EBITDA was $6.0 million, down from $6.4 million year-over-year. The company experienced a net loss of $12.7 million for the nine months ending September 30, 2020. Updated revenue guidance suggests a full-year decline of 1% to 2% year-over-year, with expectations for modest growth in Q4.
Tactile Systems Technology, Inc. (TCMD) will release its third-quarter fiscal 2020 financial results after market close on November 2. A conference call will be held at 5:00 PM ET on the same day for a detailed discussion of the results, accessible via phone and live webcast. Tactile Medical specializes in at-home treatment devices for chronic diseases like lymphedema and chronic venous insufficiency, aiming to enhance patient quality of life while reducing overall healthcare costs.